Overview

Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.

Status:
Completed
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
Phase 2b clinical trial to evaluate the safety and efficacy of intranasal application of GX-03 as a treatment and prevention for COVID-19.
Phase:
Phase 2
Details
Lead Sponsor:
Turn Therapeutics
Collaborators:
Gorgas Memorial Institute for Health Studies
Hospital Modular - Covid-19
Hospital Santo Tomas
Treatments:
Petrolatum